Sex steroid hormone function in the brain niche: Implications for brain metastatic colonization and progression

od Contreras‐Zárate, María J., Cittelly, Diana M.
Izdano u Cancer Rep (Hoboken) (2020)

Ovarian steroid hormones: what's hot in the stem cell pool?

od Cittelly, Diana M, Richer, Jennifer K, Sartorius, Carol A
Izdano 2010

miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer

od Howe, Erin N., Cochrane, Dawn R., Cittelly, Diana M., Richer, Jennifer K.
Izdano 2012

Detrimental effects of anti-apoptotic treatments in spinal cord injury

od Cittelly, Diana M, Nesic, Olivera, Johnson, Kathia, Hulsebosch, Claire, Perez-Polo, J. Regino
Izdano 2007

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

od Hanna, Colton, Kwok, Letty, Finlay-Schultz, Jessica, Sartorius, Carol A., Cittelly, Diana M.
Izdano u J Vis Exp (2016)

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors

od Cittelly, Diana M., Das, Partha M., Salvo, Virgilio A., Fonseca, Juan P., Burow, Matthew E., Jones, Frank E.
Izdano 2010

Dicer Expression in Estrogen Receptor Positive versus Triple-Negative Breast Cancer: An Antibody Comparison

od Spoelstra, Nicole S., Cittelly, Diana M., Christenson, Jessica L., Gordon, Michael A., Elias, Anthony, Jedlicka, Paul, Richer, Jennifer K.
Izdano u Hum Pathol (2016)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

od Cittelly, Diana M, Das, Partha M, Spoelstra, Nicole S, Edgerton, Susan M, Richer, Jennifer K, Thor, Ann D, Jones, Frank E
Izdano 2010

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

od Finlay-Schultz, Jessica, Cittelly, Diana M., Hendricks, Peter, Patel, Purvi, Kabos, Peter, Jacobsen, Britta M., Richer, Jennifer K., Sartorius, Carol A.
Izdano u Oncogene (2014)

Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases

od Contreras-Zárate, Maria J., Day, Nicole L., Ormond, D. Ryan, Borges, Virginia F., Tobet, Stuart, Gril, Brunilde, Steeg, Patricia S., Cittelly, Diana M.
Izdano u Oncogene (2019)

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4

od Cittelly, Diana M., Finlay-Schultz, Jessica, Howe, Erin N., Spoelstra, Nicole S., Axlund, Sunshine Daddario, Hendricks, Peter, Jacobsen, Britta M., Sartorius, Carol A., Richer, Jennifer K.
Izdano u Oncogene (2012)

MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer

od Cochrane, Dawn R., Cittelly, Diana M., Howe, Erin N., Spoelstra, Nicole S., McKinsey, Erin L., LaPara, Kelly, Elias, Anthony, Yee, Douglas, Richer, Jennifer K.
Izdano u Horm Cancer (2010)

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

od Sartorius, Carol A., Hanna, Colton T., Gril, Brunilde, Cruz, Hazel, Serkova, Natalie J., Huber, Kendra M., Kabos, Peter, Schedin, Troy B., Borges, Virginia F., Steeg, Patricia S., Cittelly, Diana M.
Izdano u Oncogene (2015)

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

od Cittelly, Diana M., Dimitrova, Irina, Howe, Erin N., Cochrane, Dawn R., Jean, Annie, Spoelstra, Nicole S., Post, Miriam D., Lu, Xian, Broaddus, Russell R., Spillman, Monique A., Richer, Jennifer K.
Izdano 2012

Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen

od Brechbuhl, Heather M., Finlay-Schultz, Jessica, Yamamoto, Tomomi M., Gillen, Austin E., Cittelly, Diana M., Tan, Aik C., Sams, Sharon, Pillai, Manoj M., Elias, Anthony D., Robinson, William A., Sartorius, Carol A., Kabos, Peter
Izdano u Clin Cancer Res (2016)

Fibroblast subtypes define a metastatic matrisome in breast cancer

od Brechbuhl, Heather M., Barrett, Alexander S., Kopin, Etana, Hagen, Jaime C., Han, Amy L., Gillen, Austin E., Finlay-Schultz, Jessica, Cittelly, Diana M., Owens, Philip, Horwitz, Kathryn B., Sartorius, Carol A., Hansen, Kirk, Kabos, Peter
Izdano u JCI Insight (2020)

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

od Contreras-Zárate, María J., Ormond, D. Ryan, Gillen, Austin E., Hanna, Colton, Day, Nicole L., Serkova, Natalie J., Jacobsen, Britta M., Edgerton, Susan M., Thor, Ann D., Borges, Virginia F., Lillehei, Kevin O., Graner, Michael W., Kabos, Peter, Cittelly, Diana M.
Izdano u Front Oncol (2017)

Reversal of Triple-negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immune-Suppression

od Rogers, Thomas J., Christenson, Jessica L., Greene, Lisa I., O’Neill, Kathleen I., Williams, Michelle M., Gordon, Michael A., Nemkov, Travis, D’Alessandro, Angelo, Degala, Greg D., Shin, Jimin, Tan, Aik-Choon, Cittelly, Diana M., Lambert, James R., Richer, Jennifer K.
Izdano u Mol Cancer Res (2018)

Activation of Wnt signaling promotes olaparib resistant ovarian cancer

od Yamamoto, Tomomi M., McMellen, Alexandra, Watson, Zachary L., Aguilera, Jennifer, Ferguson, Rebecca, Nurmemmedov, Elmar, Thakar, Tanay, Moldovan, George-Lucian, Kim, Hyunmin, Cittelly, Diana M., Joglar, Annette M., Brennecke, Elyse P., Wilson, Heidi, Behbakht, Kian, Sikora, Matthew J., Bitler, Benjamin G.
Izdano u Mol Carcinog (2019)

Combination of trastuzumab emtansine and stereotactic radiosurgery results in high rates of clinically significant radionecrosis and dysregulation of Aquaporin-4.

od Stumpf, Priscilla K., Cittelly, Diana M., Robin, Tyler P., Carlson, Julie A., Stuhr, Kelly A., Contreras-Zarate, Maria Jose, Lai, Steven, Ormond, D. Ryan, Rusthoven, Chad G., Gaspar, Laurie E., Rabinovitch, Rachel, Kavanagh, Brian D., Liu, Arthur, Diamond, Jennifer, Kabos, Peter, Fisher, Christine M.
Izdano u Clin Cancer Res (2019)